Danaher Corporation (DHR) Balance Sheet

A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments.

Total Assets Chart for Danaher Corporation

Danaher Corporation (DHR) total assets for FY2025 were USD 83.5B, a 7.6% change from FY2024. Danaher Corporation's total assets grew from USD 268.9M in 1985 to USD 83.5B in 2025 (30939.0% over 40 years). Total assets compound annual growth rate: 5-year CAGR of 1.8%, 10-year CAGR of 5.6%, 20-year CAGR of 11.7%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Assets (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$140.58B
Implied Share Price
$199.98
Enterprise Value
$159.28B
Revenue (TTM)
$25.11B
EBITDA
$8.03B
Profit Margin
15.95%
Trailing P/E
35.65
Forward P/E
22.88
Price/Book (MRQ)
2.61
Price/Sales (TTM)
5.60
EV/EBITDA
21.00
EV/Revenue
6.34
Dividend Yield
0.72%
Book Value
$74.81
Free Cash Flow (FY2025)
$5.26B
Free Cash Flow Yield
3.74%

Snapshot as of 7th August 2026 — not point-in-time controlled, may lag the live market by a few days.